inner-banner

ANZICS CTG Publications FY2023 – 2024

ANZICS CTG Publications  FY2023 – 2024

BLENDER
Blend to limit oxgyen in ECMO: A randomised controlled registry trial: Study protocol and statistical analysis plan

BLING III
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis The BLING III Randomized Clinical Trial
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock A Systematic Review and Meta-Analysis
Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis

BONANZA
Brain tissue oxygen monitoring in moderate-to-severe traumatic brain injury: Physiological determinants, clinical interventions and current randomised controlled trial evidence

DRIVE RT NZ
The Rise of Adaptive Platform Trials in Critical Care

ECMOCARD
Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation

EPO TBI LTFU
The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury

ICU RESOLVE
In-person peer support for critical care survivors: The ICU REcovery Solutions cO-Led through surVivor Engagement (ICURESOLVE) pilot randomised controlled trial

LOGICAL
Protocol summary and statistical analysis plan for the low oxygen intervention for cardiac arrest injury limitation (LOGICAL) trial

MEGA-ROX
Protocol and statistical analysis plan for the mega randomised registry trial comparing conservative vs. liberal oxygenation targets in adults in the intensive care unit with suspected hypoxic ischaemic encephalopathy following a cardiac arrest (Mega-ROX HIE)

REMAP-CAP
Simvastatin in Critically Ill Patients with Covid-19
Intravenous Vitamin C for Patients Hospitalized With COVID-19 Two Harmonized Randomized Clinical Trials

REVISE
Proton pump inhibitors in critically ill mechanically ventilated patients with COVID-19: protocol for a substudy of the Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial
REVISE: Re-Evaluating the Inhibition of Stress Erosions in the ICU: a randomised trial protocol

TARGET PROTEIN
Study protocol for TARGET protein: The effect of augmented administration of enteral protein to critically ill adults on clinical outcomes: A cluster randomised, cross-sectional, double cross-over, clinical trial

ANZICS CTG Publications  FY2022 – 2023